1.Menzies, D, Joshi, R, Pai, M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis 2007;11:593–605.
2.Harada, N, Nakajima, Y, Higuchi, K, Sekiya, Y, Rothel, J, Mori, T. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 2006;27:442–448.
3.Joshi, R, Reingold, AL, Menzies, D, Pai, M. Tuberculosis among healthcare workers in low- and middle-income countries: a systematic review. PLoS Med 2006;3:e494.
4.Menzies, D. Interpretation of repeated tuberculin tests: boosting, conversion, and reversion. Am J Respir Crit Care Med 1999;159:15–21.
5.Mazurek, GH, LoBue, PA, Daley, CL, et al.Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001;286:1740–1747.
6.Wang, L, Turner, MO, Elwood, RK, Schulzer, M, FitzGerald, JM. A metaanalysis of the effect of bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 2002;57:804–809.
7.Mazurek, GH, Villarino, ME. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003;52:15–18.
8.Menzies, R, Vissandjee, B. Effect of bacille Calmette-Guerin vaccination on tuberculin reactivity. Am Rev Respir Dis 1992;145:621–625.
9.Skjot, RL, Oettinger, T, Rosenkrands, I, et al.Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens. Infect Immun 2000;68:214–220.
10.Behr, MA, Wilson, MA, Gill, WP, et al.Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999;284:1520–1523.
11.Pai, M, Riley, LW, Colford, JM Jr.Interferon-gamma assays in the immu-nodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004;4:761–776.
12.Menzies, D, Pai, M, Comstock, G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007;146:340–354.
13.Pai, M, Zwerling, A, Menzies, D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149:177–184.
14.Hong, YP, Kim, SJ, Lew, WJ, Lee, EK, Han, YC. The seventh nationwide tuberculosis prevalence survey in Korea, 1995. Int J Tuberc Lung Dis 1998;2:27–36.
15.Lew, WJ, Lee, EG, Bai, JY, et al.An Internet-based surveillance system for tuberculosis in Korea. Int J Tuberc Lung Dis 2006;10:1241–1247.
16.Kang, YA, Lee, HW, Yoon, HI, et al.Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005;293:2756–2761.
17.Lee, SS, Liu, YC, Huang, TS, et al.Comparison of the interferon-gamma release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers. Scand J Infect Dis 2008;40:373–380.
18.Nienhaus, A, Schabion, A, Bacie, CL, Siano, B, Diel, R. Evaluation of the interferon-gamma release assay in healthcare workers. Int Arch Occup Environ Health 2008;81:295–300.
19.Jo, KW, Woo, JH, Hong, Y, et al.Incidence of tuberculosis among health care workers at a private university hospital in South Korea. Int J Tuberc Lung Dis 2008;12:436–440.
20.Jung, YJ, Park, IN, Hong, SB, et al.The clinical characteristics, diagnosis, treatment, and outcomes of patients with tuberculosis at a private university hospital in Korea. Tuberc Respir Dis 2006;60:194–204.
21.American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161: S221–247.
22.Sokal, JE. Measurement of delayed skin-test responses. N Engl J Med 1975;293:501–502.
23.Mori, T, Sakatani, M, Yamagishi, F, et al.Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004;170:59–64.
24.Brock, I, Weldingh, K, Lillebaek, T, Follmann, F, Andersen, P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 2004;170:65–69.
25.Pollock, NR, Campos-Neto, A, Kashino, S, et al.Discordant QuantiFERON-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution? Infect Control Hosp Epidemiol 2008;29:878–886.
26.Mazurek, GH, Jereb, J, Lobue, P, Iademarco, MF, Metchock, B, Vernon, A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005;54:49–55.
27.Pai, M, O'Brien, R. Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions? PLoS Med 2007;4:e208.
28.Jensen, PA, Lambert, LA, Iademarco, MF, Ridzon, R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005;54:1–141.
29.Pai, M, Joshi, R, Dogra, S, et al.T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis 2009;13:84–92.
30.Pai, M, Joshi, R, Dogra, S, et al.Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 2006;174:349–355.
31.Veerapathran, A, Joshi, R, Goswami, K, et al.T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS ONE 2008;3:e1850.
32.van Zyl-Smit, RN, Pai, M, Peprah, K, et al.Within-subject variability and boosting of T cell IFN-y responses following tuberculin skin testing. Am J Respir Crit Care Med 2009;180:49–58.